Marshall Wace
NRXP icon

Marshall Wace’s NRX Pharmaceuticals NRXP Stock Holding History

Marshall Wace’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$796K Buy
+194,580
New +$643K ﹤0.01% 2313
2025
Q4 		– Sell
-189,136
Closed -$624K – 3313
2025
Q3 		$624K Buy
189,136
+155,752
+467% +$446K ﹤0.01% 2144
2025
Q2 		$109K Sell
33,384
-55,702
-63% -$140K ﹤0.01% 2532
2025
Q1 		$183K Buy
+89,086
New +$251K ﹤0.01% 2425
2022
Q1 		– Sell
-250
Closed -$12K – 3799
2021
Q4 		$12K Buy
+250
New +$18K ﹤0.01% 3741

Other funds holding NRXP

BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Marshall Wace's NRXP Position: Q2 2026 in Review

Marshall Wace opened a new position in NRX Pharmaceuticals (NRXP) in Q2 2026: 194,580 shares worth $796K. The stake represents ﹤0.01% of the portfolio and ranks #2313 among its holdings. This is a return to the name: Marshall Wace previously reported a position in NRXP as recently as Q3 2025.

Marshall Wace first reported a position in NRXP in Q4 2021 and has held it in 5 quarters since. 46 funds tracked by Wall St. Rank hold NRXP as of Q2 2026.

  • Marshall Wace held 194,580 shares of NRX Pharmaceuticals worth $796K as of Q2 2026.
  • NRX Pharmaceuticals was a new Marshall Wace position in Q2 2026.
  • NRX Pharmaceuticals made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2313 holding.
  • Marshall Wace first reported a position in NRX Pharmaceuticals in Q4 2021 and has held it in 5 quarters since.
  • 46 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.